AncestryDNA Raw Data: Unlock Hidden Health Insights

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Genetic variants discussed here represent population-level associations, not individual diagnoses. Always consult a qualified healthcare provider before making health decisions based on genetic information.

---

What Is AncestryDNA Raw Data and Why It Matters for Health

AncestryDNA is best known as an ancestry and genealogy service, but the raw genetic data it generates contains far more information than ethnicity estimates. When you take an AncestryDNA test, the lab genotypes approximately 700,000 single nucleotide polymorphisms (SNPs) across your genome using an Illumina microarray. These SNPs are scattered across all 23 chromosome pairs and include variants with well-documented associations to health, metabolism, nutrient processing, and disease risk.

The file you can download from AncestryDNA — typically a compressed text file around 10–30 MB — contains your genotype at each of those positions in a tab-separated format: a rsID identifier, chromosome number, chromosomal position, and your two alleles (one from each parent). This format is compatible with dozens of third-party analysis tools.

Most users download their raw data to generate ancestry reports. Far fewer realize that the same file can be used to explore clinically relevant genetic variants. Researchers have cataloged thousands of SNPs with associations to cardiovascular disease, nutrient absorption, pharmacogenomics, immune function, and more. Your AncestryDNA file likely contains hundreds of these variants.

This guide explains how to extract meaningful health information from your AncestryDNA raw data, which SNPs matter most, and how to interpret what you find — responsibly.

---

How to Download Your AncestryDNA Raw Data

Downloading your raw data from AncestryDNA takes under five minutes. Here is the step-by-step process:

1. Log in to your AncestryDNA account at ancestry.com
2. Click your username in the top-right corner, then select DNA
3. Click Settings on your DNA results page
4. Scroll to the section labeled Download Raw DNA Data
5. Click Download DNA Raw Data and confirm your identity (AncestryDNA will send a confirmation email)
6. Follow the link in the email to initiate the download

The file arrives as a .zip archive. Inside you will find a .txt file with a header section (lines beginning with #) that explains the format, followed by the data rows. Each data row looks like this:

rs4477212    1    72017    AA
rs3131972    1    752721    AG

The columns are: rsID, chromosome, position, and genotype. Some positions show 00 for both alleles — these are uncalled genotypes where the microarray could not produce a reliable reading.

Once downloaded, you can upload this file to third-party tools for health analysis. If you are researching where to send your file, our comparison of the best DNA upload sites in 2026 covers the leading options in detail.

---

Which Health-Relevant SNPs Are Included in AncestryDNA Data

AncestryDNA uses the Illumina OmniExpress and custom arrays. While the chip is not optimized for clinical reporting, it captures a substantial portion of the most-studied health SNPs. Below is an overview of the major categories covered.

Cardiovascular and Lipid Metabolism

The APOE gene is one of the most studied in human genetics. The ε4 allele (defined by rs429358 C) increases Alzheimer's risk by approximately 3–4x in heterozygotes and 8–12x in homozygotes compared to the most common ε3/ε3 genotype. It also affects LDL cholesterol metabolism. The ε2 allele (rs7412 T) is generally protective.

Nutrient Metabolism

The MTHFR variants are among the most frequently asked about in consumer genetics. The C677T variant (rs1801133 TT homozygous) reduces enzyme activity by approximately 70%, impairing folate conversion and potentially elevating homocysteine. For a deeper dive, see our dedicated guide on how to check your MTHFR gene in raw data.

Pharmacogenomics

AncestryDNA covers several variants relevant to drug metabolism, though coverage is incomplete compared to dedicated pharmacogenomic panels.

---

The Best Tools to Analyze AncestryDNA Raw Data for Health

Once you have your raw data file, you need a tool to translate the rsID-genotype pairs into readable health information. Here are the main options:

Promethease

Promethease cross-references your SNPs against SNPedia, a curated wiki of published research. It generates a report organized by magnitude and frequency of effect, with links to the underlying studies. The service costs $12 and produces thousands of entries. The report can be overwhelming without context — our guide on how to read a Promethease report explains how to navigate it efficiently.

SelfDecode

SelfDecode offers a more consumer-friendly interface with wellness reports across dozens of categories. It uses polygenic scores rather than individual SNPs, which can improve predictive accuracy for complex traits. The service requires a subscription. For a detailed feature comparison, see SelfDecode vs Promethease vs Genetic Genie.

Genetic Genie

A free tool focused specifically on methylation (MTHFR and related variants) and detoxification pathway genes. It produces a one-page report covering around 30 variants. Limited in scope but useful for quick screening of these specific pathways.

AskMyDNA

AskMyDNA takes a different approach: rather than generating a static report, it lets you have a conversation with your genetic data. You upload your raw file and ask questions in plain English — "do I have the MTHFR C677T variant?", "what does my APOE genotype mean for my Alzheimer's risk?", "which vitamin D SNPs do I carry?" — and receive answers grounded in your actual genotype alongside relevant research context. The first 3 questions are free, no credit card required.

Comparison Table

If you have previously used 23andMe and are considering switching or supplementing your analysis, the process is similar — see what to do with 23andMe raw data after bankruptcy for additional context on managing consumer genetic data across platforms.

---

Key Health Categories You Can Explore from AncestryDNA Data

Cardiovascular Risk Variants

Beyond APOE, AncestryDNA data covers several variants associated with cardiovascular risk. The 9p21 chromosomal region contains the strongest common variant signal for coronary artery disease. The lead SNP in this region, rs1333049, has a per-allele odds ratio of approximately 1.3 for myocardial infarction. Carrying two copies of the risk allele (CC genotype) roughly doubles lifetime risk compared to the TT genotype, though absolute risk depends heavily on modifiable factors like diet, exercise, and smoking.

The PCSK9 gene regulates LDL receptor degradation. Loss-of-function variants in PCSK9 — several of which are covered in AncestryDNA data — are associated with dramatically lower LDL cholesterol and reduced cardiovascular events. This gene became therapeutically important when PCSK9 inhibitor drugs were developed partly by studying individuals who carried natural loss-of-function variants.

Factor V Leiden (rs6025 in the F5 gene) and Prothrombin G20210A (rs1799963) are two clotting disorder variants that AncestryDNA may cover depending on the array version. These affect venous thromboembolism risk and are relevant for decisions about oral contraceptives, surgery, and long-haul travel.

Metabolic and Weight-Related Variants

The FTO gene contains some of the most replicated obesity-associated variants in the human genome. rs9939609 in FTO has a per-allele effect of approximately 0.3–0.4 kg/m² on BMI. The AA genotype is associated with roughly 1.7 kg higher body weight on average compared to the TT genotype. While the effect size is modest, FTO variants appear to influence energy balance partly through effects on appetite regulation rather than basal metabolic rate.

The TCF7L2 gene contains rs7903146, one of the strongest common genetic signals for type 2 diabetes risk. The T allele is associated with impaired insulin secretion. Each copy of the T allele increases type 2 diabetes risk by approximately 30–40%.

Mental Health and Neurological Variants

The BDNF Val66Met variant (rs6265) affects brain-derived neurotrophic factor secretion. The Met allele is associated with differences in episodic memory, hippocampal volume, and stress response. It has been studied in the context of depression, anxiety, and response to antidepressant medications.

COMT Val158Met (rs4680) affects catechol-O-methyltransferase, an enzyme that degrades dopamine in the prefrontal cortex. The Val allele leads to faster dopamine clearance and is associated with better stress tolerance but lower baseline dopamine signaling. The Met allele is associated with better executive function under low-stress conditions but greater vulnerability to acute stress.

---

Understanding Polygenic Risk and What Single SNPs Cannot Tell You

One of the most important concepts for interpreting AncestryDNA health data is the distinction between single-variant effects and polygenic risk. Most complex diseases — heart disease, type 2 diabetes, depression, Alzheimer's — are influenced by hundreds or thousands of variants, each with small individual effects. Looking at any single SNP gives you only a fragment of the picture.

Genome-wide association studies (GWAS) have identified thousands of disease-associated variants, but even the strongest common variants explain only a small fraction of total disease heritability. A polygenic risk score (PRS) aggregates effects across many variants and can provide better risk stratification than any individual SNP.

Consider coronary artery disease: the top 50 GWAS hits together explain only about 10% of the variance in CAD risk. A comprehensive PRS using millions of variants can identify individuals in the top 8% of genetic risk who have more than triple the average lifetime risk — but this requires specialized computation that most consumer tools do not yet offer.

What this means practically:

• A "good" genotype at one SNP does not cancel a "bad" genotype at another. Risk is cumulative and context-dependent.
• A "high-risk" variant does not mean disease is inevitable. Most variants increase relative risk by 20–50%, not 10-fold.
• Environmental and behavioral factors often dwarf genetic effects. The genetic contribution to type 2 diabetes risk is roughly 40%, meaning lifestyle factors account for 60%.
• Population statistics do not predict individual outcomes. A 30% increased risk means nothing about whether you specifically will develop the condition.

This is why the most useful health genetics tools frame findings in terms of "variants worth discussing with your doctor" rather than "you will get disease X."

---

AncestryDNA vs 23andMe for Health Data: What's Different

AncestryDNA and 23andMe both use SNP microarray technology, but there are meaningful differences in their health data coverage.

23andMe includes built-in health reports for subscribers, which AncestryDNA does not offer. However, for third-party analysis, the raw data files from both platforms are largely equivalent and compatible with the same tools. The array differences mean some specific SNPs covered by one platform may be absent from the other.

If you primarily want health insights, 23andMe's paid tier provides curated reports with clearer medical context. If you already have AncestryDNA data or prefer its ancestry features, the raw data can be analyzed just as thoroughly using third-party tools.

For users who have uploaded their data to Promethease and found the experience confusing, Promethease alternatives in 2026 covers newer tools that offer more interpretable output.

---

Nutrigenomics: What Your AncestryDNA Data Reveals About Diet

Nutrigenomics — the study of how genetic variants affect nutritional needs and responses — is one of the most practically applicable areas of consumer genetics. AncestryDNA data covers a useful set of nutrigenomics variants.

Vitamin D

Vitamin D status is influenced by multiple genetic factors. Key variants in AncestryDNA data include:

• rs2282679 (GC gene): This variant affects GC protein, which binds and transports vitamin D in the blood. The A allele is associated with lower 25(OH)D levels. Studies in the UK Biobank show this variant explains about 3–5% of vitamin D level variation.
• rs10741657 (CYP2R1): Affects hepatic conversion of vitamin D3 to 25(OH)D. The A allele is associated with reduced conversion efficiency.
• rs731236 (VDR): The vitamin D receptor TaqI variant affects receptor activity. Linked to bone density, immune function, and multiple sclerosis risk in some studies.

Carriers of multiple vitamin D-reducing variants may benefit from higher supplementation doses, though optimal dosing should be guided by 25(OH)D blood testing rather than genetics alone.

Caffeine Metabolism

The CYP1A2 gene encodes the primary enzyme responsible for caffeine metabolism. rs762551 is the most studied variant: the AA genotype is associated with "fast" caffeine metabolism, while AC or CC genotypes indicate slower metabolism. Slow metabolizers show greater cardiovascular risk from coffee consumption (particularly elevated myocardial infarction risk at higher doses), while fast metabolizers appear to derive cardiovascular benefit. This is one of the clearest gene-diet interactions demonstrated in human studies.

Saturated Fat Response

The APOA2 gene, which produces apolipoprotein A-II, contains a variant (rs5082) that moderates the relationship between saturated fat intake and BMI. Individuals with the TT genotype show a stronger BMI increase in response to high saturated fat intake compared to CC or CT genotypes. Two large prospective studies have replicated this interaction.

Omega-3 Conversion

FADS1 and FADS2 genes encode fatty acid desaturase enzymes that convert plant-based omega-3s (ALA) to the longer-chain forms EPA and DHA. The major haplotype at this locus (tagged by rs174537) affects conversion efficiency by approximately 2-fold. Individuals with the low-conversion genotype may derive less benefit from plant-based omega-3 sources and may require preformed EPA/DHA from marine sources.

If you are exploring personalized nutrition, personalized supplements based on DNA covers how genetic data translates into supplement decisions across multiple nutrients.

When you want to ask specific questions about your nutrigenomics variants — "which form of folate does my MTHFR genotype suggest I need?" or "does my FADS1 variant affect how I process flaxseed oil?" — AskMyDNA lets you put those exact questions to your own genetic data. The conversational format is particularly useful for nutrigenomics, where the relevant answer depends on your specific combination of variants rather than any single SNP.

---

BRCA and Hereditary Cancer Variants: What AncestryDNA Does and Doesn't Cover

This is the area where consumer genetics most requires careful qualification. Hereditary breast and ovarian cancer (HBOC) caused by BRCA1 and BRCA2 mutations is among the most clinically actionable genetic findings available. However, AncestryDNA's coverage of these variants is limited.

What AncestryDNA Does Not Do

AncestryDNA does not perform clinical-grade BRCA testing. The service does not screen for the thousands of pathogenic and likely pathogenic variants in BRCA1 and BRCA2 that have been cataloged in ClinVar. A negative result from analyzing your AncestryDNA raw data through any third-party tool does not rule out hereditary cancer risk.

What AncestryDNA May Cover

Some specific BRCA1 and BRCA2 variants may appear in AncestryDNA raw data because they happen to be on the array, particularly the three Ashkenazi Jewish founder mutations:

• BRCA1 185delAG (rs80357914)
• BRCA1 5382insC (rs80357906)
• BRCA2 6174delT (rs80359550)

However, array-based detection of these variants is not the same as sequencing-based clinical testing. Microarrays can produce false positives and false negatives for indels (insertions and deletions), which these mutations are. A positive result from consumer data analysis should always be confirmed with clinical-grade testing before any medical decision is made.

If you have a personal or family history that raises concern about hereditary cancer, genetic counseling and clinical testing through a healthcare provider or certified genetic testing laboratory is the appropriate path — not consumer raw data analysis.

Other Cancer-Related SNPs

Beyond BRCA, there are common SNPs associated with modest increases in breast, prostate, colorectal, and other cancer risks. These are common variants with small effect sizes (typically odds ratios of 1.1–1.3 per allele) and are fundamentally different from rare high-penetrance mutations like BRCA variants. AncestryDNA covers many of these GWAS-discovered variants, and they can be included in polygenic risk score calculations, but they require careful contextualization.

---

How to Interpret Your Results Responsibly

Interpreting genetic health data without context is one of the most common sources of unnecessary anxiety and misguided health decisions among consumers. Here is a framework for approaching your results.

Step 1: Distinguish Variant Types

Not all genetic findings are equal. There is a fundamental difference between:

• Rare high-penetrance variants (like BRCA1/2 pathogenic mutations): These have strong effects and are clinically actionable, but require clinical testing, not consumer data
• Common variants with modest effect (like APOE ε4, FTO rs9939609): These shift population-level risk and are worth discussing with a doctor, but are not diagnoses
• Pharmacogenomic variants (like CYP2C19 poor metabolizer status): These can directly inform drug and dose selection and are among the most clinically useful findings from consumer data

Step 2: Look at Absolute Risk, Not Just Relative Risk

A 50% increased relative risk sounds alarming, but the actual magnitude depends entirely on baseline risk. If the lifetime risk of a condition is 2%, a 50% relative increase means your risk is 3% — a 1 percentage point difference. Context matters.

Step 3: Consult Clinical Resources

For any finding you want to act on:

• Search the rsID at ClinVar for clinical interpretations
• Check OMIM for gene-disease relationships
• Review the original GWAS data at GWAS Catalog
• Bring findings to a healthcare provider who can integrate genetic data with your medical history

Step 4: Verify with Clinical Testing When Warranted

For clinically significant findings — potential BRCA mutations, factor V Leiden, hereditary hemochromatosis (HFE variants), familial hypercholesterolemia — clinical confirmation testing is essential before making medical decisions.

AskMyDNA is designed to help with Step 1 and Step 3 above: quickly identifying what variants you carry and providing research context in plain language. For variant-specific questions, you can ask directly and get answers referenced to your actual genotype — a more efficient process than manually looking up dozens of rsIDs in SNPedia. New users get 3 free questions without entering payment information.

For a broader view of what free analysis tools can and cannot reveal, free DNA health analysis: what you're missing is a useful complement to this guide.

---

FAQ

Can AncestryDNA raw data tell me if I have the BRCA1 or BRCA2 mutation?

AncestryDNA raw data has very limited BRCA1/BRCA2 coverage and is not a substitute for clinical testing. Some specific variants, including the three Ashkenazi Jewish founder mutations, may appear in the raw data file, but microarray-based detection is not reliable for insertions and deletions. A negative result does not rule out BRCA mutations. If hereditary cancer risk is a concern, seek genetic counseling and clinical-grade sequencing.

Is AncestryDNA raw data accurate enough for health analysis?

The genotyping accuracy of AncestryDNA raw data is high for SNPs — typically above 99.5% concordance with clinical genotyping for well-called variants. However, coverage is incomplete compared to whole genome sequencing or clinical panels. About 10–15% of positions may show uncalled genotypes (00), and the array does not cover all medically relevant variants. For population-associated SNPs with small effect sizes, the accuracy is generally sufficient for educational analysis.

What is the difference between AncestryDNA and a clinical genetic test?

Consumer DNA tests like AncestryDNA use SNP microarrays that genotype a selected set of ~700,000 positions. Clinical genetic tests can range from targeted single-gene tests to full exome or whole genome sequencing. Clinical tests are validated to regulatory standards (CLIA/CAP certified labs), include genetic counseling, and are interpreted by licensed geneticists. Consumer tests are not designed for clinical decision-making. The distinction matters most for high-penetrance conditions like HBOC or hereditary arrhythmias.

Can I use AncestryDNA data to optimize my diet and supplements?

Yes — with appropriate expectations. AncestryDNA data covers a useful set of nutrigenomics variants including MTHFR (folate metabolism), FADS1/FADS2 (fatty acid conversion), CYP1A2 (caffeine), VDR and GC (vitamin D), and lactase persistence (LCT). These findings can meaningfully inform dietary choices and supplement selection. The key limitation is that nutrigenomics effects are typically modest and interact with baseline diet, gut microbiome, and other factors. Genetic guidance works best as one input among several, alongside blood testing and response monitoring.

How long does it take to get useful health information from AncestryDNA raw data?

Once you have downloaded your raw data file, analysis can begin immediately. Static report tools like Promethease generate results in a few minutes. Conversational tools like AskMyDNA give instant answers to specific questions. The more time-consuming part is interpretation — reading through hundreds of Promethease entries can take hours without a clear framework. Targeted analysis (asking specific questions about variants relevant to your health history) is generally more efficient than trying to review everything at once.

---

Conclusion

AncestryDNA raw data contains significantly more health-relevant information than most users realize. With approximately 700,000 SNPs covering cardiovascular risk, nutrient metabolism, pharmacogenomics, neurological variants, and more, the same file generated for ancestry purposes can be a useful starting point for understanding your genetic predispositions.

The key is using the data thoughtfully. Single SNPs rarely determine outcomes. Polygenic effects, environmental factors, and clinical context are all essential for accurate interpretation. The most actionable findings from consumer genetic data tend to be pharmacogenomic variants, nutrient metabolism variants like MTHFR, and population risk scores for common conditions — categories where genetic guidance can meaningfully complement standard medical care.

For rare, high-penetrance conditions like hereditary cancer syndromes, consumer data analysis is not sufficient and clinical testing remains the standard. For the broad landscape of common complex disease risk and lifestyle optimization, AncestryDNA raw data provides a useful educational foundation.

Start with specific questions relevant to your health history, verify interesting findings through clinical resources, and bring significant findings to a qualified healthcare provider. That workflow turns a genealogy file into genuinely useful health information.

---

References:

1. Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics. 2013. PubMed

2. Frosst P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics. 1995. PubMed

3. Genome-wide association study of 14,000 cases of seven common diseases. Wellcome Trust Case Control Consortium. Nature. 2007. PubMed

4. Stram DO. Design, Analysis and Interpretation of Genome-Wide Association Scans. NIH/NHGRI GWAS Catalog. EBI GWAS Catalog

5. ClinVar: public archive of relationships among sequence variation and human phenotype. NCBI ClinVar. ClinVar

6. Lango Allen H, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010. PubMed

7. Cornelis MC, et al. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006. PubMed